Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04064086 · ClinicalTrials.gov registry record · NA

Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans

A NA study of Chronic Kidney Disease and End Stage Renal Disease, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
656
Enrollment target
1
Study location

NCT04064086: Active NA study of Chronic Kidney Disease and End Stage Renal Disease, sponsored by VA Office of Research and Development.

NCT04064086 is a NA study of Chronic Kidney Disease and End Stage Renal Disease that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 656 participants, below the 3,200-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04064086, a NA study of Chronic Kidney Disease and End Stage Renal Disease, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
656 participants
Enrollment target
1
Study location

Study Summary

This study is intended to correct an important systemic deficit in the care of chronic kidney disease (CKD), VHA's fourth most common healthcare condition with high mortality and healthcare burden. Currently, many Veterans with CKD have poor awareness of their condition. This leads to suboptimal care. The investigators anticipate that the proposed comprehensive pre-end stage renal disease (ESRD) education (CPE) will enhance Veterans' CKD knowledge and their confidence in making an informed selection of an appropriate dialysis modality, and lead to an increase in the use of home dialysis (HoD) - an evidence-based, yet underutilized dialysis modality. Further, this study will allow us to examine whether such Veteran-informed dialysis choice can improve Veteran and health services outcomes. If successful, this study may deliver a ready to roll-out strategy to meet the CKD care needs of the Veterans and reduce VHA healthcare costs.

Primary Outcome

Patient receiving either CPE or Enhanced usual care (EUC) will be followed for the diagnosis of ESRD and initiation of dialysis. The investigators will follow the use of peritoneal dialysis or home hemodialysis at day 90 into the dialysis as the home dialysis (HoD) use primary outcome.

Interventions

  • OTHER Comprehensive Pre-ESRD Patient Education (CPE)
  • OTHER Provision of the freely available resources for Kidney Disease Education

Study Locations (1)

Florida

  • North Florida/South Georgia Veterans Health System, Gainesville, FL - Gainesville

Trial Details

FieldValue
Enrollment Target 656 participants
Start Date 2020-03-25
Est. Completion 2027-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the registry record for NCT04064086 still lists

NCT04064086 is an interventional study that assigns participants to a tested intervention. The registered 656 participants enrollment target is mid-sized for trials with a published cap, below the 3,200-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (79% lower).

The record links to 4 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 2 interventions - of which Comprehensive Pre-ESRD Patient Education (CPE) is the first listed.

NCT04064086 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04064086 about?

NCT04064086 is a clinical study titled "Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans". This study is intended to correct an important systemic deficit in the care of chronic kidney disease (CKD), VHA's fourth most common healthcare condition with high mortality and healthcare burden. Currently, many Veterans with CKD have poor awareness of their condition. This leads to suboptimal car...

What is the current status of trial NCT04064086?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 656 participants. The study started on 2020-03-25. Estimated completion is 2027-09-30.

What conditions does trial NCT04064086 study?

This clinical trial studies the following conditions: Chronic Kidney Disease, End Stage Renal Disease, Hemodialysis, Peritoneal Dialysis.

What interventions are being tested in trial NCT04064086?

The interventions under investigation include: Comprehensive Pre-ESRD Patient Education (CPE) (OTHER), Provision of the freely available resources for Kidney Disease Education (OTHER).

Who is sponsoring clinical trial NCT04064086?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04064086 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04064086's enrollment target sits among peer trials

656 23rd of 101 higher than 79 of 101 other Chronic Kidney Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05407129 · 656 participants · NA

    Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences

  • NCT06127199 · 656 participants · NA

    Contraceptive Efficacy Study of Ovaprene

  • NCT03671044 · 657 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

  • NCT05338697 · 657 participants

    Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04064086, the US trial registry maintained by the National Library of Medicine. NCT04064086 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.